The ACTC repository is under review for potential modification in compliance with Administration directives.
Faculty, Staff, and researchers

Our People

Featured researcher

Paul Aisen, MD

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.
Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease Alzheimers Dement.
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease Nat Rev Neurol.
Learn More
Featured researcher

Cecily Jenkins, PhD

Recently Published Works
Safety, Efficacy, and Feasibility of Intranasal insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA Neurol. 2020 Sep 1;77(9):1099-1109
Recognitions
Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research Alzheimers Res Ther. 2020 Jun 30;12(1):78. doi: 10.1186/s13195-020-00643-0
Panels & Presentations
Identification of Alzheimer disease risk by functional magnetic resonance imaging Arch Neurol. 2005 Dec;62(12):1881-8. doi: 10.1001/archneur.62.12.1881.
Learn More

Leadership & Faculty

Team Leads

Administration Team

Alzheimer’s Clinical Trial Consortium (ACTC) Team

Biomarker And Basic Science Teams

Biostatistics Team

Clinical Monitoring Team

Clinical Operations Team

Data Management Team

Informatics Team

Information Technology Team

Medical Monitoring Team

Neuropsychology Team

Neuroscience Translational Research Division (NTRD) Team

Participant Support Team

Recruitment, Engagement and Retention Team

Regulatory Affairs Team

Events

Finance

Quality Assurance

Shared Services